114. Genova, A., Dix, O., Thakur, M., & Sangha, P. S. (2020). Chronic non-cancer pain management and addiction: A review. Cureus, 12(2), e6963. https:// doi.org/10.7759/cureus.6963 115. Zelaya, C. E; Dahlhamer, J. M; Lucas, J. W; Connor, EM. (2020). Chronic pain and high-impact chronic pain among US adults, 2019. NCHS Data Brief No. 390. Retrieved September 22, 2022 from https:// www.cdc.gov/nchs/products/databriefs/db390.htm 116. Goodwin, J. & Bajwa, Z. H. (2016). Evaluating the patient with chronic pain. In C. A. Warfield &Z. H. Bajwa (Eds.). Principles and practice of pain medicine (3rd ed.) McGraw-Hill Companies, Inc. 117. Tauben, D; Stacey, B. R. (2022a). Evaluation of chronic non-cancer pain in adults. Up to Date. Retrieved September 22, 2022 from https://www. uptodate.com/contents/evaluation-of-chronic-non- cancer-pain-in-adults 118. Dowell, D., Haegerich, T. M., & Chou R. (2016). CDC guideline for prescribing opioids in chronic pain—United States. JAMA, 315(15), 1624–1645. https://doi.org/10.1001/jama.2016.1464 119. Racine, M. (2018). Chronic pain and suicide risk: A comprehensive review. Progress in Neuro- Psychopharmacology & Biological Psychiatry, 87(Pt B), 269–280. https://doi.org/10.1016/j. pnpbp.2017.08.020 120. Indian Health Service. (2021). Function-Based Objectives. Retrieved September 22, 2022 from www.ihs.gov/painmanagement/treatmentplanning/ functionbasedobjectives/. 121. US Department of Veterans Affairs. (2020). Goal setting for pain rehabilitation. Retrieved September 22, 2022 from https://www.va.gov/ WHOLEHEALTHLIBRARY/tools/goal-setting-for- pain-rehabilitation.asp 122. Hooten M, Thorson D, Bianco J, Bonte B, Clavel Jr A, Hora J, Johnson C, Kirksson E, Noonan MP, Reznikoff C, Schweim K, Wainio J, Walker N. (2017). Pain: Assessment, Non-Opioid Treatment Approaches and Opioid Management. Institute for Clinical Systems Improvement. Retrieved September 22, 2022 from https://www.icsi.org/wp-content/ uploads/2019/01/Pain.pdf 123. Tauben, D; Stacey, B. R. (2022b). Approach to the management of chronic non-cancer pain in adults. Up to Date. Retrieved September 22, 2022 from https://www.uptodate.com/contents/approach-to- the-management-of-chronic-non-cancer-pain-in- adults 124. National Institutes of Health-National Center for Complementary and Alternative Medicine (NCCAM) (2016). Acupuncture: In Depth. Retrieved September 22, 2022 from https://nccih.nih.gov/ health/acupuncture/introduction 125. Rubinstein, S. M., van Middelkoop, M., Assendelft, W. J., de Boer, M. R., & van Tulder, M. W. (2011). Spinal manipulative therapy for chronic low-back pain. The Cochrane database of systematic reviews, (2), CD008112. https://doi.org/10.1002/14651858. CD008112.pub2 126. Chou, R. (2021). Subacute and chronic low back pain: Nonpharmacologic and pharmacologic treatment. Up to Date. Retrieved September 16, 2022 from https://www.uptodate.com/ contents/subacute-and-chronic-low-back-pain- nonpharmacologic-and-pharmacologic-treatment 127. Pierce-Smith, D; Goode, P; Hurd, R. (2022). OTC Pain Medicines and Their Risks. University of Rochester Medical Center. Retrieved September 22, 2022 from https://www.urmc.rochester.edu/encyclopedia/ content.aspx?contenttypeid=134&contentid=130
128. Gerriets, V., Anderson, J., Nappe, T.M. Acetaminophen. (2021). Acetaminophen. StatPearls Publishing. Retrieved September 16, 2022 from https://www.ncbi.nlm.nih.gov/books/ NBK482369/ 129. Tauben, D; Stacey, B. R. (2022c). Pharmacologic management of chronic non-cancer pain in adults. Retrieved September 22, 2022 from https:// www.uptodate.com/contents/pharmacologic- management-of-chronic-non-cancer-pain-in-adults 130. Solomon, DH. (2022a). Nonselective NSAIDs: Overview of adverse effects. Up to Date. Retrieved September 22, 2022 from https://www.uptodate. com/contents/nonselective-nsaids-overview-of- adverse-effects 131. Solomon, DH. (2022b). Overview of COX-2 selective NSAIDs. Up to Date. Retrieved September 22, 2022 from https://www.uptodate.com/contents/overview- of-cox-2-selective-nsaids 132. Bermas, B L. (2022). Safety of rheumatic disease medication use during pregnancy and lactation. Up to Date. Retrieved September 22, 2022 from https://www.uptodate.com/contents/safety- of-rheumatic-disease-medication-use-during- pregnancy-and-lactation 133. Cook, R. (2022). Subacute and chronic low back pain: nonpharmacologic and pharmacologic treatment. Up to Date. Retrieved September 16, 2022 from https://www.uptodate.com/ contents/subacute-and-chronic-low-back-pain- nonpharmacologic-and-pharmacologic-treatment 134. Knight, CL; Deyo, RA; Staiger, TO; Wipf, JE. (2022). Treatment of acute low back pain. Up to Date. Retrieved September 16, 2022 from https://www. uptodate.com/contents/treatment-of-acute-low- back-pain 135. Bystritsky, A. (2022). Pharmacotherapy for generalized anxiety disorder in adults. Up to Date. Retrieved September 16, 2022 from https:// www.uptodate.com/contents/generalized-anxiety- disorder-in-adults-management 136. Nelson, C. (2022). Serotonin-norepinephrine reuptake inhibitors (SNRIs): Pharmacology, administration, and side effects. Up to Date. Retrieved September 16, 2022 from https://www. uptodate.com/contents/serotonin-norepinephrine- reuptake-inhibitors-snris-pharmacology- administration-and-side-effects 137. Hirsch, M; Birnbaum, R. (2022). Tricyclic and tetracyclic drugs: Pharmacology, administration, and side effects. Up to Date. Retrieved September 22, 2022 from https://www.uptodate.com/contents/ tricyclic-and-tetracyclic-drugs-pharmacology- administration-and-side-effects 138. Centers for Disease Control and Prevention (CDC). (2021a). Understanding the epidemic. Retrieved September 22, 2022 from https://www.cdc.gov/ drugoverdose/epidemic/index.html 139. Substance Abuse and Mental Health Services Administration. (2021). Key substance use and mental health indicators in the United States: Results from the 2020 National Survey on Drug Use and Health. Retrieved September 22, 2022 from https://www.samhsa.gov/data/sites/default/ files/reports/rpt35325/NSDUHFFRPDFWHTML- Files2020/2020NSDUHFFR1PDFW102121.pdf 140. Minnesota.gov. (2021). Chronic pain opioid prescribing recommendations. Retrieved September 22, 2022 from https://mn.gov/dhs/opip/opioid- guidelines/pain-phase/chronic-pain.jsp#ppa
141. Laks, J., Alford, D. P., Patel, K., Jones, M., Armstrong, E., Waite, K., Henault, L., & Paasche-Orlow, M. K. (2021). A national survey on patient provider agreements when prescribing opioids for chronic pain. Journal of General Internal Medicine, 36(3), 600–605. https://doi.org/10.1007/s11606-020- 06364-2 142. Indian Health Service. (2020). Informed Consent. Retrieved September 22, 2022 from https://www. ihs.gov/painmanagement/treatmentplanning/ informedconsent/. 143. Fudin, J. (2018). Opioid Agonists, Partial Agonists, Antagonists: Oh My! Retrieved September 22, 2022 from https://www.pharmacytimes.com/contributor/ jeffrey-fudin/2018/01/opioid-agonists-partial- agonists-antagonists-oh-my 144. Stolbach, A & Hoffman, R. S. (2022). Acute opioid intoxication in adults. UpToDate. Retrieved September 22, 2022 from https://www.uptodate. com/contents/acute-opioid-intoxication-in-adults 145. Benzon, H; Raja, S; Fishman, S; Liu, S; Cohen, S. (2018). Essentials of Pain Medicine, Fourth Edition. Elsevier. 146. Centers for Disease Control and Prevention (CDC). (2022). Fentanyl. Retrieved September 20, 2022 from https://www.cdc.gov/opioids/basics/fentanyl. html 147. Alderks, C. E. (2017). Trends in the use of methadone, buprenorphine, and extended- release naltrexone at substance abuse treatment facilities: 2003-2015 (Update). The CBHSQ Report: August 22, 2017. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. 148. Krueger, C. (2019). Methadone for pain management. Practical Pain Management. Retrieved September 22, 2022 from https:// www.practicalpainmanagement.com/treatments/ pharmacological/opioids/methadone-pain- management 149. Food and Drug Administration (FDA). (n.d.). Methadone hydrochloride. Retrieved September 22, 2022 from https://www.accessdata.fda.gov/ drugsatfda_docs/label/2015/006134s038lbl.pdf 150. Substance Abuse and Mental Health Services Administration. (2018). SAMHSA opioid overdose prevention toolkit. HHS Publication No. (SMA) 18–4742. S. Retrieved September 22, 2022 from https://store.samhsa.gov/system/files/sma18- 4742.pdf 151. Michigan State University College of Human Medicine. (n.d.). Pain relief for terminally ill patients. Retrieved September 22, 2022 from http://learn. chm.msu.edu/painmanagement/chooseopioid.asp 152. McAuley, D. (2017). Pain management, opiates. The clinician’s ultimate reference. Retrieved September 22, 2022 from http://www.globalrph.com/pain.htm 153. Food and Drug Administration (FDA). (2018). FDA drug safety communication: Prescription acetaminophen products to be limited to 325 mg per dosage unit; Boxed warning will highlight potential for severe liver failure. Retrieved September 22, 2022 from https://www.fda.gov/drugs/drug-safety- and-availability/fda-drug-safety-communication- prescription-acetaminophen-products-be-limited- 325-mg-dosage-unit 154. Kishner, S. (2018). Opioid equivalents and conversions. Retrieved September 22, 2022 from https://emedicine.medscape.com/ article/2138678-overview
42
Powered by FlippingBook